Please ensure Javascript is enabled for purposes of website accessibility
Home / Information / References

RIOK3 potentially regulates osteogenesis-related pathways in ankylosing spondylitis and the differentiation of bone marrow mesenchymal stem cells
2024-10-09 47

Affiliations

  • Department of Rheumatology and Immunology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Department of Rheumatology and Immunology, the First Affiliated Hospital of Anhui Medical University, Hefei, China. xsqian-1112@163.com.

PMID:  37866658 DOI: 10.1016/j.ygeno.2023.110730

Abstract

Background: RNA-binding proteins (RBPs) are crucial for gene expression and immune regulation. This study explored the role of RBPs in ankylosing spondylitis (AS) and identified RIOK3 as a key RBP influencing disease pathogenesis.

Methods: RNA-seq was used to analyze PBMCs from five AS patients and three healthy individuals, identifying RIOK3 as a significant RBP. siRNA knockdown experiments in mBMSCs were performed to understand its impact on gene expression.

Results: RIOK3 knockdown inhibited osteogenic differentiation and ribosome function in mBMSCs, suggesting its involvement in pathological bone formation in AS.

Conclusion: RIOK3 may play a critical role in AS pathogenesis by influencing bone formation, making it a potential target for therapeutic intervention.

Keywords

Ankylosing spondylitis; Bioinformatics; Bone marrow mesenchymal stem cell; New bone formation; RNA-binding proteins.

Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only